Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Nociceptin

Base Information
  • Chemical Name:Nociceptin
  • CAS No.:170713-75-4
  • Deprecated CAS:171778-43-1
  • Molecular Formula:C79H129 N27 O22
  • Molecular Weight:1809.06
  • Hs Code.:
  • UNII:7AYI9N34FF
  • ChEMBL ID:CHEMBL396460
  • DSSTox Substance ID:DTXSID60168933
  • Wikidata:Q4327722
  • Wikipedia:Nociceptin
  • Mol file:170713-75-4.mol
Nociceptin

Synonyms:N-OFQ peptide;nociceptin;nociceptin-orphanin FQ;orphanin FQ

Suppliers and Price of Nociceptin
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Sigma-Aldrich
  • Nociceptin
  • 1mg
  • $ 151.70
  • Sigma-Aldrich
  • Orphanin FQ ≥95%(HPLC)
  • 1MG
  • $ 149.50
  • ChemScene
  • Nociceptin 99.83%
  • 25mg
  • $ 1320.00
  • ChemScene
  • Nociceptin 99.83%
  • 10mg
  • $ 612.00
  • ChemScene
  • Nociceptin 99.83%
  • 5mg
  • $ 336.00
  • ChemScene
  • Nociceptin 99.83%
  • 1mg
  • $ 84.00
  • Cayman Chemical
  • Nociceptin
  • 1mg
  • $ 70.00
  • Cayman Chemical
  • Nociceptin
  • 500μg
  • $ 39.00
  • Cayman Chemical
  • Nociceptin
  • 5mg
  • $ 273.00
  • ApexBio Technology
  • Nociceptin
  • 10mg
  • $ 803.00
Total 29 raw suppliers
Chemical Property of Nociceptin
Chemical Property:
  • PKA:3.19±0.10(Predicted) 
  • PSA:831.40000 
  • Density:1.47±0.1 g/cm3(Predicted) 
  • LogP:1.07680 
  • Storage Temp.:−20°C 
  • XLogP3:-10.2
  • Hydrogen Bond Donor Count:30
  • Hydrogen Bond Acceptor Count:27
  • Rotatable Bond Count:64
  • Exact Mass:1807.98054885
  • Heavy Atom Count:128
  • Complexity:3720
Purity/Quality:

99%, *data from raw suppliers

Nociceptin *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N
  • Isomeric SMILES:C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)O
  • General Description Nociceptin (also known as orphanin FQ) is an endogenous neuropeptide that acts as the natural ligand for the nociceptin receptor (NOP), an orphan opioid receptor involved in modulating pain, cough, and other physiological processes. The study explores synthetic NOP-targeting ligands, demonstrating their potential as selective antitussive agents with reduced side effects compared to conventional opioids. While the research focuses on novel NOP ligands rather than nociceptin itself, it underscores the receptor's role in cough suppression and the therapeutic promise of NOP-selective compounds. **Returned paragraph:** Nociceptin (orphanin FQ) is an endogenous peptide ligand for the nociceptin receptor (NOP), which regulates physiological functions such as pain and cough. The development of selective NOP ligands, like the 3-substituted N-benzhydryl-nortropane analogs, highlights the receptor's therapeutic potential for cough treatment with improved safety over traditional opioids.
Refernces

Structure-activity relationships of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the treatment of cough

10.1016/j.bmcl.2008.10.088

The study investigates the structure–activity relationships (SAR) of 3-substituted N-benzhydryl-nortropane analogs as potential nociceptin receptor (NOP) ligands for treating cough. NOP, also known as ORL-1, is an orphan opioid receptor involved in various physiological processes, including cough mediation. The researchers synthesized a series of 3-axial-aminomethyl-N-benzhydryl-nortropane analogs and explored their binding affinity and selectivity for NOP over classic opioid receptors like MOP. Key chemicals involved include tropinone, which was demethylated and alkylated to form a ketone intermediate, and tosylmethyl isocyanide used in the transformation to a nitrile intermediate. The nitriles were further modified to aminomethyl or substituted aminomethyl groups using lithium aluminum hydride (LAH) and other reagents. The synthesized compounds were tested for their binding affinity at the cloned human nociceptin receptor and their functional activities. Compound 18 showed potent NOP binding affinity with a Ki of 6 nM and superior selectivity over MOP binding. Selected compounds demonstrated good DMPK profiles and potent oral antitussive activity in a guinea pig model, with compound 21 showing an ED50 of 0.19 mg/kg at 2 hours. The study highlights the potential of these analogs as novel therapeutic agents for cough management with improved side effect profiles compared to traditional opioid-based antitussives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 170713-75-4